DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,592,893 | +7.5% | 10,451 | +4.0% | 1.75% | +13.2% |
| Q2 2023 | $2,412,480 | -5.1% | 10,052 | -0.3% | 1.54% | -9.5% |
| Q1 2023 | $2,542,327 | -1.0% | 10,087 | +4.3% | 1.71% | +27.3% |
| Q4 2022 | $2,566,877 | +3.6% | 9,671 | +0.8% | 1.34% | -29.8% |
| Q3 2022 | $2,478,000 | -0.7% | 9,594 | -2.5% | 1.91% | +7.4% |
| Q2 2022 | $2,495,000 | -12.4% | 9,841 | +1.4% | 1.78% | +5.4% |
| Q1 2022 | $2,847,000 | 0.0% | 9,705 | +12.2% | 1.69% | +51.8% |
| Q4 2021 | $2,847,000 | +3.0% | 8,653 | -4.7% | 1.11% | -23.8% |
| Q3 2021 | $2,765,000 | +3.3% | 9,082 | -8.9% | 1.46% | +6.8% |
| Q2 2021 | $2,676,000 | +17.9% | 9,973 | -1.1% | 1.36% | +11.0% |
| Q1 2021 | $2,270,000 | 0.0% | 10,084 | -1.3% | 1.23% | -2.4% |
| Q4 2020 | $2,270,000 | +3.1% | 10,218 | -0.1% | 1.26% | -5.8% |
| Q3 2020 | $2,201,000 | +23.2% | 10,225 | +1.3% | 1.34% | +12.2% |
| Q2 2020 | $1,786,000 | +36.4% | 10,098 | +6.7% | 1.19% | +16.1% |
| Q1 2020 | $1,309,000 | -6.5% | 9,463 | +3.8% | 1.03% | +24.2% |
| Q4 2019 | $1,400,000 | +8.7% | 9,117 | +2.3% | 0.83% | -1.9% |
| Q3 2019 | $1,288,000 | +35.6% | 8,915 | +34.2% | 0.84% | +28.3% |
| Q2 2019 | $950,000 | +18.0% | 6,645 | +8.9% | 0.66% | +15.9% |
| Q1 2019 | $805,000 | +37.4% | 6,100 | +7.3% | 0.57% | +24.6% |
| Q4 2018 | $586,000 | -2.8% | 5,685 | +2.4% | 0.46% | +11.0% |
| Q3 2018 | $603,000 | +11.5% | 5,550 | +1.3% | 0.41% | +5.9% |
| Q2 2018 | $541,000 | +4.2% | 5,480 | +3.3% | 0.39% | +11.2% |
| Q1 2018 | $519,000 | +34.5% | 5,305 | +27.7% | 0.35% | +42.0% |
| Q4 2017 | $386,000 | +13.9% | 4,155 | +5.1% | 0.24% | +10.9% |
| Q3 2017 | $339,000 | +14.9% | 3,955 | +13.3% | 0.22% | +16.9% |
| Q2 2017 | $295,000 | +8.9% | 3,490 | +10.1% | 0.19% | +13.2% |
| Q1 2017 | $271,000 | +35.5% | 3,170 | +59.7% | 0.17% | +39.2% |
| Q2 2016 | $200,000 | – | 1,985 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |